Study of the interaction between ofloxacin and human serum albumin by spectroscopic methods

Luminescence

Volumn 26, Issue 6, 2011, Pages 710-715

  Varlan, Aurica ^a   Ionescu, Sorana ^a   Hillebrand, Mihaela ^a  

^a UNIVERSITY OF BUCHAREST   (Romania)

Author keywords

circular dichroism; fluorescence quenching; human serum albumin; molecular modelling; ofloxacin

Indexed keywords

BINDING ENERGY; BODY FLUIDS; DICHROISM; ENERGY TRANSFER; FLUORESCENCE QUENCHING; SPECTROSCOPIC ANALYSIS;

BINDING PARAMETER; CIRCULAR DICHROISM SPECTRUMS; COMPETITIVE BINDING; ENERGY-TRANSFER; FLUORESCENCE QUENCHING; FLUORESCENCE QUENCHING METHOD; FORSTER; HUMAN SERUM ALBUMINS; OFLOXACIN; SPECTROSCOPIC METHOD;

MOLECULAR MODELING;

EID: 83555161585     PISSN: 15227235     EISSN: 15227243     Source Type: Journal    
DOI: 10.1002/bio.1302     Document Type: Article

References (38)

1. Peters T,. Serum albumin. In Advances in protein chemistry. New York: Academic Press, 1985; 37: 161-245.
2. Carter DC, Ho JX,. Serum albumin: structure. In Advances in protein chemistry. New York: Academic Press, 1994; 45: 153-203.
3. Steinhard J, Krijn J, Leidy JG,. Differences between bovine and human serum albumins. Binding isotherms, optical rotatory dispersion, viscosity, hydrogen ion titration, and fluorescence effects. Biochemistry 1971; 10: 4005-15.
4. Silva D, Cortez CM, Cunha-Bastos J, Louro SRW,. Methyl parathion interaction with human and bovine serum albumin. Toxicol Lett 2004; 147: 53-61. (Pubitemid 38045319)
5. Bertucci C, Domenici E,. Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance. Curr Med Chem 2002; 9: 1463-81. (Pubitemid 34823027)
6. Kragh-Hansen U,. Molecular aspects of ligand binding to serum albumin. Pharmacol Rev 1981; 33: 17-53.
7. Mandell GL, Sandle MA, Gilman AG, Rall ThW, Nies AS, Tayler P, (eds). The pharmacological basis of therapeutics. Pergamon: Oxford, 1991; 1047-64.
8. Margioris A, Gravanis A, Chrousos GP,. Glucocorticoids and Mineralocorticoids. Chapter 35. In Human Pharmacology: Molecular to Clinical, Brody T, Larner J, Minneman K, Neu HC, (eds.). St. Louis: Mosby-Yearbook, 1994: 473-481.
9. Barbosa J, Berges R, Sanz-Nebot V,. Retention behaviour of quinolone derivatives in high-performance liquid chromatography. Effect of pH and evaluation of ionization constants. J Chromatogr A 1998; 823: 411-22. (Pubitemid 28461844)
10. Hayakawa I, Atarashi S, Yokohama S, Imamura M, Sakano K, Furukawa M,. Synthesis and antibacterial activities of optically active ofloxacin. Antimicrob Agents Chemother 1986; 29: 163-4. (Pubitemid 16155244)
11. Shyamali SS, Lillian DR, Lawrence L, Esther B,. Fluorescence studies of native and modified neurophysins: effects of peptides and pH. Biochemistry 1979; 18: 1026-36.
12. 1H-NMR spectra of oligonucleotides by two-dimensional NMR spectroscopy: application to a lac operator fragment. J Magn Reson 1985; 62: 378-86.
13. Eftink MR, Ghiron CA,. Fluorescence quenching studies with proteins. Anal Biochem 1981; 144: 199-27.
14. Zhang L-W, Wang K, Zhang X-X,. Study of the interactions between fluoroquinolones and human serum albumin by affinity capillary electrophoresis and fluorescence method. Anal Chim Acta 2007; 603: 101-10. (Pubitemid 47562353)
15. Guo M, Lu W-J, Yi P-G, Yu Q-S,. Study on the thermodynamic characteristics between fluoroquinolone and bovine serum albumin. J Chem Thermodyn 2007; 39: 337-43. (Pubitemid 46096960)
16. Kamat BP,. Study of the interaction between fluoroquinolones and bovine serum albumin. J Pharm Biomed Anal 2005; 39: 1046-50. (Pubitemid 41441736)
17. Ni Y, Sub S, Kokot S,. Spectrometric studies on the interaction of fluoroquinolones and bovine serum albumin. Spectrochim Acta A 2010; 75: 547-52.
18. Hu YJ, Ou-Yang Y, Bai AM, Li W, Liu Y,. Investigation of the Interaction between ofloxacin and bovine serum albumin: spectroscopic approach. J Solution Chem 2010; 39: 709-17.
19. Lee BH, Yeo G-Y, Jang KJ, Lee D-J, Noh SG, Cho T-S,. A thermodynamic study on the interaction of quinolone antibiotics and DNA. Bull Korean Chem Soc 2009; 30: 1031-4.
20. Sanner MF,. Python: a programming language for software integration and development. J Mol Graph Model 1999; 17: 57-61. (Pubitemid 30029318)
21. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE,. The Protein Data Bank. Nucleic Acids Res 2000; 28: 235-42. (Pubitemid 30047768)
22. Schmidt MW, Baldridge KK, Boatz JA, Elbert ST, Gordon MS, Jensen JH, Koseki S, Matsunaga N, Nguyen KA, Su SJ, Windus TL, Dupuis M, Montgomery JA,. General atomic and molecular electronic structure system. J Comput Chem 1993; 14: 1347-63.
23. Eftink MR,. Fluorescence quenching reactions: probing biological macromolecular structures. In Biophysical and biochemical aspects of fluorescence spectroscopy, Eewey TG, (ed.). New York: Plenum, 1991: 1-41.
24. Lakowicz JR, Weber G,. Quenching of fluorescence by oxygen: a probe for structural fluctuations in micromolecules. Biochemistry 1973; 12: 4161-70.
25. Bi SY, Song DQ, Ding L, Tian Y, Zhou X, Liu X, Zhang HQ,. Molecular spectroscopic study on the interaction of tetracyclines with serum albumins. Spectrochim Acta A 2005; 61: 629-36. (Pubitemid 40072640)
26. Sudlow G, Birkett DJ, Wade DN,. The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol 1975; 11: 824-32.
27. Sudlow G, Birkett DJ, Wade DN,. Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol 1976; 12: 1052-61.
28. Wanwimolruk S, Birkett DJ, Brooks PM,. Structural requirements for drug binding to site II on human serum albumin. Mol Pharmacol 1983; 24: 458-63. (Pubitemid 14249842)
29. Förster T, Sinanoglu O,. Modern quantum chemistry. New York: Academic Press, 1966: 93-137.
30. Weert M,. Fluorescence quenching to study protein-ligand binding: common errors. J Fluoresc 2010; 20: 625-9.
31. 1-acid glycoprotein (orosomucoid) and the glycosylation site of the protein. Carbohydr Res 2003; 338: 2233-6. (Pubitemid 38352687)
32. Abert WC, Gregory WM, Allan GS,. The binding interaction of Coomassie blue with protein. Anal Biochem 1993; 213: 407-13.
33. Klajnert B, Bryszewska M,. Fluorescence studies on PAMAM dendrimers interactions with bovine serum albumin. Bioelectrochemistry 2002; 55: 33-55.
34. Trynda-Lemiesz L,. Paclitaxel-HSA interaction. Binding sites on HSA molecule. Bioorg Med Chem 2004; 12: 3269-75. (Pubitemid 38680716)
35. Lee JY, Hirose M,. Partially folded state of the disulfide-reduced form of human serum albumin as an intermediate for reversible denaturation. J Biol Chem 1999; 274: 29303-10.
36. Yang P, Gao F,. The principles of bioinorganic chemistry. Beijing: Science, 2002.
37. Li Y, He W, Liu J, Sheng F, Hu Z, Chen X,. Binding of the bioactive component Jatrorrhizine to human serum albumin. Biochim Biophys Acta 2005; 1722: 15-21. (Pubitemid 40222400)
38. Lu ZX, Cui T, Shi QL,. Applications of circular dichroism and optical rotatory dispersion in molecular biology, 1st edn. Science Press, Beijing, 1987; 79-82.